Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2008The Journal of ImmunologyOpen Access

The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAnya SchneiderVirginia Mason Medical CenterMRMary RieckStanford UniversitySSSrinath SandaUniversity of California, San Francisco

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schneider et al. (2008) studied this question.

synapsesocial.com/papers/6a6f9e4e5d37378ac1dcacd2https://doi.org/10.4049/jimmunol.181.10.7350
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function2004 · 563 citations
  2. 2Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes Development2003 · 236 citations
  3. 3TNF downmodulates the function of human CD4+CD25hi T-regulatory cells2006 · 779 citations
  4. 4Allograft rejection mediated by memory T cells is resistant to regulation2007 · 214 citations
  5. 5Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes2005 · 864 citations